Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Transplantation: full-pipeline trial registry
8 of 35 indexed Kidney Transplantation trials are currently recruiting.
Corpus placement: #435 of 28,707 conditions by registered trial count.
35 US clinical trials · 8 currently recruiting · #435 of 28,707 conditions by registered trial count
Kidney Transplantation: 35 US clinical trials tracked, 8 recruiting.
Kidney Transplantation is the subject of 35 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 8 are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 4 of these trials.
Enrollment posture brief
Registry condition kidney-transplantation
OPEN 8 | RECR 23% | LATE 8 | EARLY 12 | RANK #435 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Atherosclerosis (23% recruiting · 70 trials)
Kidney Transplantation lists 8 open slots (23% of 35 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Transplantation is recruiting below its size-band peers.
8 of 35 indexed trials (22.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Kidney Transplantation trials is spread across many organizations.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 4 of 35 trials (11.4%). 26 distinct sponsors appear on at least one study for this condition label.
-
Typical Kidney Transplantation enrolment sits around 88 participants.
Median target enrolment is 88 among the 34 trials that report a genuine target (sentinel values excluded). 18 of those (52.9%) plan for fewer than 100 participants.
-
Kidney Transplantation research is mostly interventional.
30 interventional and 5 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
35 total, page 1 of 1
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
University of British Columbia
NCT03674307
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
Mayo Clinic
NCT06568549
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
Hennepin Healthcare Research Institute
NCT05879302
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
United Therapeutics
NCT06878560
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
United Therapeutics
NCT07224763
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Alexion Pharmaceuticals
NCT06744647
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Singulera Therapeutics
NCT06552169
Prehabilitation for Kidney Transplant Candidates
The Methodist Hospital Research Institute
NCT06886256
APOL1 Genetic Testing Program for Living Donors
Northwestern University
NCT04910867
Watermelon/UBIQuinone Study
University of California, San Francisco
NCT04972552
The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients
Amit D Tevar, MD
NCT03809533
Envarsus XR® in Adolescent Renal Transplant Recipients
University of California, Los Angeles
NCT03266393
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
ITB-Med
NCT04803058
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
Astellas Pharma Europe
NCT02118896
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
Hoffmann-La Roche
NCT00087581
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
Astellas Pharma
NCT00113269
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00007787
Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients
Pfizer
NCT00483756
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
Astellas Pharma
NCT00543569
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01289717
Does an Abdominal Wall Nerve Block During Surgery Help Reduce Pain From Kidney Transplantation?
The Cleveland Clinic
NCT05280197
Intervention to Improve Adherence in Teen Kidney Transplant
McGill University Health Centre/Research Institute of the McGill University Health Centre
NCT01356277
Vitamin D Replacement After Kidney Transplant
University of Nebraska
NCT00748618
An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00000935
Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients
State University of New York - Downstate Medical Center
NCT00433134
HLA-Identical Sibling Renal Transplant Tolerance
Northwestern University
NCT00619528
Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients
Pfizer
NCT01375127
Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation
Vanderbilt University
NCT00305396
CCFZ533X2201 - PoC Study in de Novo Renal Transplantation
Novartis Pharmaceuticals
NCT02217410
Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient
Pfizer
NCT00263328
Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients
Novartis Pharmaceuticals
NCT00098241
Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant
Weill Medical College of Cornell University
NCT01271465
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
University of Wisconsin, Madison
NCT00078559
Tolerance by Engaging Antigen During Cellular Homeostasis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03504241
Intraperative Assessment of Renal Perfusion Using Infrared Imaging
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00595179
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 7 |
| Phase 3 | 3 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Transplantation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Transplantation page
35 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Kidney Transplantation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Kidney Transplantation trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Transplantation condition card totals 35 registered trials; most-linked intervention Tacrolimus; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.